Revised SPC: Venclyxto (venetoclax) 10 mg film-coated tablets
The SPC has been updated to include 5-year follow-up data from the MURANO randomised Phase III study, which evaluated venetoclax in combination with rituximab for the treatment of patients with CLL who had received at least one prior therapy.
Source:
electronic Medicines compendium